Role of short course intravenous methylprednisolone in the management of sudden sensorineural hearing loss
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20210063Keywords:
Sudden sensorineural hearing loss, Methylprednisolone, SteroidsAbstract
Background: Steroids have proven efficacy in the management of sudden sensorineural hearing loss (SSNHL); however, the mode of delivery and the duration of the treatment varies amongst different centres and a consensus is yet to be established. The aim of this study was to determine the efficacy of short course intravenous methylprednisolone in the management of SSNHL.
Methods: This retrospective study was conducted in the department of ENT and head and neck surgery, TUTH, institute of medicine, Kathmandu, Nepal. Record data of the cases from January 2019 to May 2020, who met the criteria of SSNHL and had received intravenous methylprednisolone for three days, were assessed for the demographic profile, duration and degree of hearing loss, co-morbidities, and hearing improvement after the therapy. Cases with incomplete documentation were excluded. Pre-admission and three days post steroid therapy pure tone audiogram investigation were compared to see the improvement retrospectively. Institutional review committee clearance was taken.
Results: Out of 32 patients, the male: female ratio was 1.7:1. Mean hearing loss prior to intravenous Methylprednisolone was 77.84 dB whereas mean hearing loss three days post intravenous methylprednisolone was 69.41dB. Three patients had complete recovery, sixteen had partial recovery and thirteen had no recovery after giving three days of intravenous methylprednisolone.
Conclusions: Short course intravenous methylprednisolone is effective in the treatment of SSNHL with minimal side effects.
Metrics
References
Chandrasekhar S, Do B, Schwartz S, Bontempo L, Faucett E, Finestone S et al. Clinical Practice Guideline: Sudden Hearing Loss (Update). Otolaryngol Head Neck Surg. 2019;161:S1-45.
Alexander TH, Harris JP. Incidence of sudden sensorineural hearing loss. Otol Neurotol. 2013;34:1586-9.
Byl FM. Seventy-six cases of presumed sudden hearing loss occurring in 1973: prognosis and incidence. Laryngoscope. 1977;87:817-25.
Kleyn AD. Sudden complete or partial loss of function of the octavus-system in apparently normal persons. Acta Oto-Laryngologica. 1944;32(5-6):407-29.
Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss: a double-blind clinical study. Arch otolaryngol. 1980;106(12):772-6.
Byl FM, Jr. Sudden hearing loss: eight years’ experience and suggested prognostic table. Laryngoscope. 1984;94:647-61.
Stokroos RJ, Albers FW, Schirm J. The etiology of idiopathic sudden sensorineural hearing loss. Experimental herpes simplex virus infection of the inner ear. Am j otol. 1998;19(4):447-52.
Fetterman BL, Saunders JE, Luxford WM. Prognosis and treatment of sudden sensorineural hearing loss. Otology Neurotol. 1996;17(4):529-36.
Koca ÇF. Evaluation of idiopathic sudden sensorineural hearing loss. Int J Otorhinolaryngol Head and Neck Surg. 2015;1(1):2.
Baysal E, Tunç O, Baglam T, Durucu C, Oz A, Karatas ZA et al. Systemic steroid versus combined systemic and intratympanic steroid treatment for sudden sensorineural hearing loss. J Craniofacial Surg. 2013;24(2):432-4.
Rauch SD, Halpin CF, Antonelli PJ. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA. 2011;305:2071-9.
Lin RJ, Krall R, Westerberg BD, Chadha NK, Chau JK. Systematic review and meta-analysis of the risk factors for sudden sensorineural hearing loss in adults. Laryngoscope. 2012;122(3):624-35.
Eftekharian A, Amizadeh M. Pulse steroid therapy in idiopathic sudden sensorineural hearing loss: A randomized controlled clinical trial. Laryngoscope.2016;126(01):150-55.
Veldman JE, Hanada T, Meeuwsen F. Diagnostic and therapeutic dilemmas in rapidly progressive sensorineural hearing loss and sudden deafness a reappraisal of immune reactivity in inner ear disorders. Acta oto-laryngologica. 1993;113(3):303-6.
Narozny W, Sicko Z, Przewozny T, Stankiewicz C, Kot J, Kuczkowski J. Usefulness of high dosed of glucocorticoids and hyberbaric oxygen therapy in sudden sensorineural hearing loss treatment. Otol Neurotol. 2004;25:916-23.
Raghunandhan S, Agarwal AK, Natarajan K, Murali S, Kumar RA, Kameswaran M. Effect of intravenous administration of steroids in the management of sudden sensori-neural hearing loss: our experience. Indian J Otolaryngol Head Neck Surg. 2013;65(3):229-33.
